Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of CNS disorders

Details for Australian Patent Application No. 2009322187 (hide)

Owner The United States of America, as Represented by the Secretary, Department of Health and Human Services

Inventors Law, Amanda J.; Weinberger, Daniel R.

Agent Cullens

Pub. Number AU-A-2009322187

PCT Pub. Number WO2010/065923

Priority 61/119,978 04.12.08 US

Filing date 4 December 2009

Wipo publication date 10 June 2010

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/065923 Priority application(s): WO2010/065923

30 June 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 Jun 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322199-Pharmaceutical dispensing system and associated method

2009322185-Antibody design using anti-lipid antibody crystal structures